Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
A little goes a long way
Size: 5 MG / 10 MG
72-week results) 2 JAMA Network (2023)Tirzepatide (SURMOUNT) obesity trials: efficacy and safety data (~20% weight loss at 15 mg weekly) 3 The Lancet (2023)Tirzepatide in type 2 diabetes: Phase 2 trial (weight loss and glycemic outcomes at 36 weeks) 4 PubMed / NEJM (2023)Tirzepatide dosing and tolerability: starting at 2 mg vs 4 mg reduces GI adverse events 5 Metabolites (PMC, 2025)TirzepatideA Game Changer in Obesity Pharmacotherapy (comprehensive review of mechanism and trials) 6 New England Journal of Medicine (2022)Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1, NEJM 2022) 7 PubMed (2025)Meta-analysis: Tirzepatide achieves ~14% greater weight reduction vs placebo with no increase in adverse events 8 Molecular Metabolism (2025)Preclinical tri-agonist NN1706 (related compound): mechanism and pharmacokinetics 9 Nature Reviews Endocrinology (2024)Dual GIP/GLP-1 receptor agonists for obesity and diabetes: a clinical landscape review 10 Journal of Cachexia, Sarcopenia and Muscle (PMC)Protein requirements during weight loss: preserving lean mass 11 GenScriptPeptide Storage and Handling Guidelines (technical bulletin for lyophilized and reconstituted peptides) 12 BachemHandling and Storage Guidelines for Peptides (technical article on stability and freeze-thaw cycles) 13 Centers for Disease Control and Prevention (CDC)Vaccine Administration: Subcutaneous Injection (technique, angle, and site guidance) 14 NCBI BookshelfInjection Administration Best Practices (aseptic technique, sharps disposal, and safety) 15 Pharmacologic Considerations of the Subcutaneous Route (PMC)Subcutaneous injection technique and site rotation to prevent lipohypertrophy 16 Prime Lab PeptidesTirzepatide (10 mg) product page (quality documentation and specifications) Tirzepatide frequently asked questions How do I reconstitute a 10 mg vial of Tirzepatide
Are there any side effects to peptide therapy
By the time most people are diagnosed, their bodys long-term B12 reserves (which are stored in the liver) are completely empty
